About Encore Path

Tailwind^™, Encore Path's debut product, permanently improves arm movement in patients who have lost upper extremity function due to stroke or other brain injuries. The U.S. Food and Drug Administration designated Tailwind, formerly BATRAC^™ (Bilateral Arm Trainer with Rhythmic Auditory Cueing), as an exercise device for stroke rehabilitation.

As a clinically proven treatment for stroke symptoms related to arm function, Tailwind is cost-effective and non-invasive. Most importantly its portability allows you to use this medical device in the comfort and privacy of your home without assistance from a physical therapist or caregiver. It’s a holistic approach to stroke recovery and can be purchased directly from Encore Path without a prescription.

Founded in 2006, we are a Baltimore, Maryland-based medical device company established to improve the quality of life for stroke survivors. Encore Path holds exclusive license to market Tailwind worldwide from the University of Maryland, Baltimore, holder of the patent. Encore Path develops and commercializes University of Maryland School of Medicine-researched technologies, devices and therapies designed to enhance rehabilitation after stroke safely and affordably.